This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2010-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2014
Title: Innovations by Shuichi Sato in Overactive Bladder Remedies
Introduction
Shuichi Sato is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing remedies for overactive bladder conditions. With a total of 3 patents, his work has garnered attention for its potential impact on patient care.
Latest Patents
One of Shuichi Sato's latest patents involves a remedy for overactive bladder comprising an acetic acid anilide derivative as the active ingredient. The compound, specifically (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or its salt, demonstrates a potent bladder relaxation effect in the isolated rat bladder smooth muscle relaxation test. It dose-dependently lowers the contraction frequency of rhythmic bladder contractions in the rat rhythmic bladder contraction measurement test. Furthermore, it prolongs the urination intervals in the urination functions measurement test on cyclophosphamide-induced overactive bladder model rats. Owing to these effects, this compound is useful as a remedy for overactive bladder.
Career Highlights
Shuichi Sato is currently associated with Astellas Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments that address common yet challenging health issues.
Collaborations
Shuichi has collaborated with notable coworkers, including Toshiyuki Takasu and Masashi Ukai. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Shuichi Sato's contributions to the development of remedies for overactive bladder highlight his innovative spirit and dedication to improving patient outcomes. His work at Astellas Pharma GmbH and his patented inventions are paving the way for future advancements in this important area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
